Clinical Trial Update: Tofersen in Non-SOD1 ALS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of tofersen for non-SOD1 amyotrophic lateral sclerosis is currently recruiting, exploring safety and potential efficacy in this ALS subse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Qalsody (Tofersen)

Snippet

Sponsor: Washington University School of Medicine | Conditions: ALS (Amyotrophic Lateral Sclerosis) | Phase 2 | Status: RECRUITING